Not Yet RecruitingNot Applicable

Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome

Taiwan400 participantsStarted 2026-03-01

Plain-language summary

The purpose of this clinical trial is to evaluate the efficacy of Jing Si Herbal Tea as an adjuvant treatment for patients diagnosed with Chronic Pelvic Pain Syndrome (CPPS). The study aims to determine whether adding Jing Si Herbal Tea to standard care can improve clinical symptoms and quality of life in these patients.

Who can participate

Age range18 Years – 100 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male patients.
✓. Diagnosed with Chronic Pelvic Pain Syndrome (CPPS) at the investigational site.
✓. Currently receiving continuous follow-up and medical treatment.

Exclusion criteria

✕. Female patients (Excluded because the standard treatment, alpha-blockers, is not approved or reimbursed by the National Health Insurance for this indication in women in Taiwan).
✕. Duration of symptoms less than 3 months.
✕. History of recurrent urinary tract infections.
✕. Diagnosed with malignancy.
✕. Hospitalization for other diseases within the past 3 months.
✕. Unwilling to participate in the study.

What they're measuring

Change in National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Total Score

Timeframe: Baseline, Month 1, Month 2, Month 3, Month 6, and Month 12

Trial details

NCT IDNCT07357142

SponsorTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-12-31

Contact for this trial

Chun-Kai Hsu, Doctor of Medicine

+886-2-6628-9779 svevi0614@gmail.com

View on ClinicalTrials.gov More Chronic Pelvic Pain Syndrome (CPPS) trials